News | Clinical Decision Support | July 14, 2017 | Jeff Zagoudis, Associate Editor

CMS Proposes Delaying Clinical Decision Support Documentation to 2019

First year would be designated for “educational and operational testing,” with no penalties for not consulting appropriate use criteria

CMS Proposes Delaying Clinical Decision Support Documentation to 2019

July 14, 2017 — In a series of proposed rule changes to the Medicare Physician Fee Schedule (MPFS) released July 13, the Centers for Medicare and Medicaid Services (CMS) pushed back the start date for when providers will be required to consult clinical decision support (CDS) for advanced diagnostic imaging to 2019. CMS indicated the first year would be considered an “educational and operational testing year,” meaning claims would still be paid on advanced diagnostic imaging services that do not indicate appropriate use criteria (AUC) were consulted.

The proposed rule change marks the second time that required CDS reporting has been delayed. The rule was first included in the final Stage 3 Meaningful Use guidelines for electronic health records (EHRs) and was slated to go into effect Jan. 1, 2017. At the time, however, there were no federal guidelines for development of CDS software, and vendors said it would take at least a year to create and implement the software once guidelines were available. As a result, the date was pushed back to Jan. 1, 2018.

The proposed rule also notes that CMS is expanding the list of qualified provider-led entities (PLEs) that are permitted to develop AUC and clinical decision support tools for various subspecialties.  The list of qualified provider-led entities as of June 2017 includes:

  • The American College of Radiology (ACR);
  • The Society for Nuclear Medicine and Molecular Imaging (SNMMI);
  • The American College of Cardiology Foundation;
  • Banner University Medical Group-Tucson University of Arizona;
  • CDI Quality Institute;
  • Cedars-Sinai Health System;
  • Intermountain Healthcare;
  • Massachusetts General Hospital Department of Radiology;
  • Medical Guidelines Institute;
  • Memorial Sloan Kettering Cancer Center;
  • National Comprehensive Cancer Network;
  • Sage Evidence-based Medicine & Practice Institute;
  • University of California Medical Campuses;
  • University of Utah Health;
  • University of Washington School of Medicine;
  • Virginia Mason Medical Center; and
  • Weill Cornell Medicine Physicians Organization.

CMS is seeking comment from stakeholders on whether CDS implementation should be delayed beyond 2019 and how long the testing period should last (if providers believe it should be longer than a year).

Use of clinical decision support tools will also help providers qualify for incentives under the Merit-Based Incentive Payment System (MIPS), part of CMS’ new Quality Payment Program (QPP) to encourage the shift toward value-based care. The QPP — which includes MIPS and the Alternative Payment Models (APM) track — will replace the Physician Quality Reporting System (PQRS), enacted in 2011, as the primary mechanism to incentivize providers to practice and report on high-quality patient care. With the initial MIPS reporting period underway this year, CMS announced several adjustments for the final PQRS reporting period in the July 13 proposed rule:

Individual eligible professionals and group practices who did not satisfactorily report data on quality measures in 2016 are subject to a downward payment adjustment of 2 percent in 2018 to their MPFS services;

The agency also proposed changing the number of required reporting measures from nine to six across the three National Quality Strategy domains of the PQRS. This change is meant to better align PQRS reporting requirements with MIPS data submission requirements for the quality performance category.

 

Read the article “CMS to Require Appropriate Use Criteria Documentation for Medical Imaging Orders”

Watch the VIDEO “Clinical Decision Support Requirements for Cardiac Imaging”

 

For more information: www.cms.gov


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now